{"transactions":[{"id":740219,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T16:52:10.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 10, 2026 or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":5.97,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001689375-26-000034","document":"wk-form4_1781297526.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000168937526000034/wk-form4_1781297526.xml","form_type":"4"}},{"id":746488,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-08T16:00:20.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":24372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2027 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":24372,"derivative":{"exercise_price":14.31,"expiration_date":"2036-06-03","underlying":"Common Stock","underlying_shares":24372},"source":{"system":"sec-edgar","filing":"0001193125-26-261647","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000119312526261647/ownership.xml","form_type":"4"}},{"id":768243,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T16:31:31.000Z","date":"2026-05-20","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.8632,"value":29316.0,"ownership":{"direct":false,"nature":"By Bernhardt G Zeiher and Paula B Zeiher Revocable Living Trust Agreement"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.86 to $6.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001689375-26-000030","document":"wk-form4_1779395488.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000168937526000030/wk-form4_1779395488.xml","form_type":"4"}},{"id":930631,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:27.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on January 26, 2027."}],"balance_after":84458,"source":{"system":"sec-edgar","filing":"0001493152-26-003809","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003809/ownership.xml","form_type":"4"}},{"id":1113768,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T08:06:15.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 11, 2025 or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":7.9,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001689375-25-000031","document":"wk-form4_1749729970.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000168937525000031/wk-form4_1749729970.xml","form_type":"4"}},{"id":1118273,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-09T16:06:03.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 5, 2026 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":5.05,"expiration_date":"2035-06-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000950170-25-083709","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000095017025083709/ownership.xml","form_type":"4"}},{"id":1193740,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-24T16:15:37.000Z","date":"2025-03-20","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.7005,"value":37005.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0000950170-25-043849","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000095017025043849/ownership.xml","form_type":"4"}},{"id":1288475,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T01:37:38.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on January 31, 2026."}],"balance_after":47145,"source":{"system":"sec-edgar","filing":"0001493152-25-004755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004755/ownership.xml","form_type":"4"}},{"id":1434286,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-14T21:10:11.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":11044,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on August 13, 2025."}],"balance_after":11044,"source":{"system":"sec-edgar","filing":"0001493152-24-032393","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224032393/ownership.xml","form_type":"4"}},{"id":1479428,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T16:34:50.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 13, 2024  or (ii) the Issuer's next annual meeting of\nstockholders."}],"balance_after":16000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001689375-24-000035","document":"wk-form4_1718397283.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000168937524000035/wk-form4_1718397283.xml","form_type":"4"}},{"id":1487207,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-07T16:49:06.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":5753,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in full upon the earlier of (i) June 6, 2025 or (ii) the date of the next annual meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date."}],"balance_after":5753,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-05","underlying":"Common Stock","underlying_shares":5753},"source":{"system":"sec-edgar","filing":"0000950170-24-070797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000095017024070797/ownership.xml","form_type":"4"}},{"id":1575011,"issuer":{"id":259,"kind":"organization","name":"Amylyx Pharmaceuticals, Inc.","symbol":"AMLX"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-15T16:35:07.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the shares subject to the option shall vest on the first anniversary of the date of grant, and the remaining two-thirds will vest in equal monthly installments over two years, provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director of the Issuer."}],"balance_after":50000,"derivative":{"exercise_price":3.17,"expiration_date":"2034-03-13","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-24-032246","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000095017024032246/ownership.xml","form_type":"4"}},{"id":1929137,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38851,"kind":"person","name":"Zeiher Bernhardt G","position":1,"cik":"0001971421","reported_name":"Zeiher Bernhardt G","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T17:17:15.000Z","date":"2023-04-04","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in equal monthly installments over three years from the date of grant, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":32000,"derivative":{"exercise_price":14.43,"expiration_date":"2033-04-04","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001689375-23-000025","document":"wf-form4_168064301724542.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1971421/000168937523000025/wf-form4_168064301724542.xml","form_type":"4"}}]}